Zhejiang Hisoar Pharmaceutical Co Ltd (002099) — Financial Flexibility Index
Zhejiang Hisoar Pharmaceutical Co Ltd (002099) has a Financial Flexibility Index of 0.01x as of September 2025. Free cash flow of CN¥31.99 Million (operating CF CN¥15.48 Million minus capex CN¥16.52 Million) represents 0% of total liabilities (CN¥2.17 Billion). Check Zhejiang Hisoar Pharmaceutical Co Ltd (002099) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Zhejiang Hisoar Pharmaceutical Co Ltd Financial Flexibility Index (2003–2024)
Historical Financial Flexibility Index trend for Zhejiang Hisoar Pharmaceutical Co Ltd across 22 annual periods. For the full cash flow conversion analysis, see Zhejiang Hisoar Pharmaceutical Co Ltd (002099) cash flow conversion.
Annual Financial Flexibility Index for Zhejiang Hisoar Pharmaceutical Co Ltd (2003–2024)
Year-by-year free cash flow to debt coverage for Zhejiang Hisoar Pharmaceutical Co Ltd. Explore how well can Zhejiang Hisoar Pharmaceutical Co Ltd service its debt to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.13x | CN¥296.94 Million | CN¥174.83 Million | CN¥2.32 Billion | ▼ -37.7% |
| 2023 | 0.21x | CN¥393.61 Million | CN¥240.54 Million | CN¥1.92 Billion | ▲ +58.9% |
| 2022 | 0.13x | CN¥295.52 Million | CN¥116.09 Million | CN¥2.29 Billion | ▼ -25.8% |
| 2021 | 0.17x | CN¥331.92 Million | CN¥102.36 Million | CN¥1.91 Billion | ▼ -62.0% |
| 2020 | 0.46x | CN¥608.05 Million | CN¥533.87 Million | CN¥1.33 Billion | ▼ -39.4% |
| 2019 | 0.76x | CN¥773.04 Million | CN¥612.40 Million | CN¥1.02 Billion | ▲ +18.7% |
| 2018 | 0.64x | CN¥1.05 Billion | CN¥791.45 Million | CN¥1.64 Billion | ▲ +488.2% |
| 2017 | 0.11x | CN¥251.67 Million | CN¥102.68 Million | CN¥2.32 Billion | ▼ -69.3% |
| 2016 | 0.35x | CN¥753.73 Million | CN¥629.42 Million | CN¥2.14 Billion | ▼ -41.5% |
| 2015 | 0.60x | CN¥758.52 Million | CN¥462.16 Million | CN¥1.26 Billion | ▲ +65.3% |
| 2014 | 0.36x | CN¥360.62 Million | CN¥191.56 Million | CN¥988.73 Million | ▲ +57.2% |
| 2013 | 0.23x | CN¥342.64 Million | CN¥60.85 Million | CN¥1.48 Billion | ▼ -54.9% |
| 2012 | 0.51x | CN¥607.51 Million | CN¥180.73 Million | CN¥1.18 Billion | ▲ +15.9% |
| 2011 | 0.44x | CN¥310.14 Million | CN¥92.62 Million | CN¥698.17 Million | ▼ -31.8% |
| 2010 | 0.65x | CN¥327.39 Million | CN¥180.88 Million | CN¥502.28 Million | ▲ +86.3% |
| 2009 | 0.35x | CN¥151.98 Million | CN¥98.38 Million | CN¥434.48 Million | ▲ +34.6% |
| 2008 | 0.26x | CN¥121.01 Million | CN¥30.61 Million | CN¥465.58 Million | ▼ -34.7% |
| 2007 | 0.40x | CN¥163.75 Million | CN¥51.14 Million | CN¥411.69 Million | ▼ -2.6% |
| 2006 | 0.41x | CN¥164.47 Million | CN¥61.88 Million | CN¥402.66 Million | ▲ +46.5% |
| 2005 | 0.28x | CN¥109.81 Million | CN¥36.07 Million | CN¥393.76 Million | ▼ -16.1% |
| 2004 | 0.33x | CN¥84.90 Million | CN¥42.36 Million | CN¥255.35 Million | ▲ +139.6% |
| 2003 | 0.14x | CN¥38.48 Million | CN¥-5.45 Million | CN¥277.36 Million | — |